Request Demo
Last update 31 Jan 2026
CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)
Last update 31 Jan 2026
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms 1928zT2-CAR-T |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)NCT04605666
CD19-Chimeric Antigen Receptor-T2 Cells for CD19 Positive Relapsed/Refractory B Cell Leukemia/Lymphoma
NCT02822326
CD19-CAR-T2 Cells for Relapse/Refractory CD19 Positive Acute Leukemia-a Phase I Trial
100 Clinical Results associated with CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Translational Medicine associated with CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Patents (Medical) associated with CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Deals associated with CD19-CAR-T2 Cells(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Phase 2 | China | 01 May 2020 | |
| CD19 Positive B-Cell Leukemia | Phase 2 | China | 01 May 2020 | |
| Refractory Acute Leukemia | Phase 1 | China | 01 Jan 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 3 | arkopidapn(zjxgzalxqf) = bsboreitab axwvbruchk (ykwkpbtyrn ) View more | Positive | 20 Feb 2018 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free